SCHEMBL7334203

SCHEMBL7334203

CC(C)C(NC(=O)N(C)C(C)c1ccccn1)C(=O)Oc1ccc([N+](=O)[O-])cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GAA P10253 3/20 0.41
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
OPRK1 P41145 2/20 0.41
RAB9A P51151 2/20 0.41
MITF O75030 1/20 0.41
AGTR1 P30556 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 4/20 0.37
TSHR P16473 2/20 0.37
ABCB11 O95342 1/20 0.37
ESR1 P03372 1/20 0.37
CYP3A4 P08684 1/20 0.37
ADRA2A P08913 1/20 0.37
CYP2C9 P11712 1/20 0.37
PDE4A P27815 1/20 0.37
ADRA1A P35348 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4680500 0.83 CA2 (0.51) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL4680503 0.83 CA2 (0.51) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL7334206 0.80 KMT2A (0.47) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL7311190 0.79 TRPM8 (0.45) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL7311193 0.79 TRPM8 (0.45) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL7333765 0.77 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL4679037 0.77 KMT2A (0.48) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL4679034 0.77 KMT2A (0.48) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL4679457 0.76 CA2 (0.46) ALDH1A1SMN1; SMN2GAAKDM4ELMNA
SCHEMBL4679453 0.76 CA2 (0.46) ALDH1A1SMN1; SMN2GAAKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0997459-A1 Intermediates for preparing retroviral protease inhibiting compounds Abbott Laboratories (US) 2000-05-03 EP disclosed
US-5837873-A PROTECTED OXYDIAMINES ABBOTT LABORATORIES (US) 1998-11-17 US disclosed
US-5648497-A Retroviral protease inhibiting compounds ABBOTT LABORAOTRIES (US) 1997-07-15 US disclosed
US-5616714-A PYRIDYL, THIAZOLYL-SUBSTITUTED AMINO ACID DERIVATIVES ABBOTT LABORATORIES (US) 1997-04-01 US disclosed
US-5597926-A Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1997-01-28 US disclosed
US-5554783-A (2R, 3R, 4S, 5S)-3-ACETOXY-2,5-BIS/BENZYLOXYCARBONYLAMINO/ -4-BROMO-1,5-DIPHENYLHEXANE ABBOTT LABORATORIES (US) 1996-09-10 US disclosed
US-5541334-A TREATING HIV ABBOTT LABORATORIES (US) 1996-07-30 US disclosed
US-5354866-A Treating HIV infections ABBOTT LABORATORIES (US) 1994-10-11 US disclosed
EP-0486948-A2 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1992-05-27 EP disclosed